Critical Survey: Accolade (NASDAQ:ACCD) versus Dazed (OTCMKTS:MEDH)

Accolade (NASDAQ:ACCD) and Dazed (OTCMKTS:MEDH) are both business services companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, institutional ownership, profitability and dividends.

Valuation & Earnings

This table compares Accolade and Dazed”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Accolade	$441.03 million	0.62	-$99.81 million	($1.03)	-3.32
Dazed	$450,000.00	N/A	N/A	N/A	N/A

Dazed has lower revenue, but higher earnings than Accolade.

Volatility & Risk

Accolade has a beta of 2.07, suggesting that its share price is 107% more volatile than the S&P 500. Comparatively, Dazed has a beta of 3.13, suggesting that its share price is 213% more volatile than the S&P 500.

Profitability

This table compares Accolade and Dazed’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Accolade	-18.16%	-18.43%	-10.35%
Dazed	-55.24%	N/A	N/A

Analyst Ratings

This is a breakdown of current recommendations for Accolade and Dazed, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Accolade	0	3	11	0	2.79
Dazed	0	0	0	0	0.00

Accolade presently has a consensus target price of $8.96, indicating a potential upside of 161.94%. Given Accolade’s stronger consensus rating and higher probable upside, research analysts clearly believe Accolade is more favorable than Dazed.

Insider and Institutional Ownership

85.0% of Accolade shares are held by institutional investors. 8.2% of Accolade shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Accolade beats Dazed on 7 of the 10 factors compared between the two stocks.

About Accolade

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.

About Dazed

Dazed, Inc. focuses on retail, distribution, hospitality, licensing, and franchising of portfolio of counterculture brands. The company was formerly known as MedX Holdings, Inc. and changed its name to Dazed, Inc. in October 2022. Dazed, Inc. was founded in 2004 and is based in Cheyenne, Wyoming.